$115 Million is the total value of Endurant Capital Management LP's 34 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 92.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $27,147,318 | – | 6,100 | +100.0% | 23.70% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $8,113,248 | – | 93,600 | +100.0% | 7.08% | – |
| LH | Sell | LABORATORY CORP AMER HLDGS | $7,859,877 | -24.3% | 32,569 | -28.0% | 6.86% | +28.7% |
| CI | Sell | THE CIGNA GROUP | $7,243,970 | +2.0% | 25,816 | -7.1% | 6.32% | +73.3% |
| MRK | Sell | MERCK & CO INC | $5,692,419 | +7.9% | 49,332 | -0.5% | 4.97% | +83.5% |
| A | New | AGILENT TECHNOLOGIES INC | $5,502,881 | – | 45,762 | +100.0% | 4.80% | – |
| THC | Sell | TENET HEALTHCARE CORP | $4,722,970 | +32.7% | 58,036 | -3.1% | 4.12% | +125.5% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $4,352,029 | -35.5% | 60,808 | -37.5% | 3.80% | +9.5% |
| IQV | New | IQVIA HLDGS INC | $4,308,616 | – | 19,169 | +100.0% | 3.76% | – |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $3,779,421 | -84.8% | 43,602 | -82.9% | 3.30% | -74.2% |
| BDX | Sell | BECTON DICKINSON & CO | $3,527,174 | -81.5% | 13,360 | -82.6% | 3.08% | -68.5% |
| BSX | New | BOSTON SCIENTIFIC CORP | $3,299,003 | – | 60,991 | +100.0% | 2.88% | – |
| CAH | New | CARDINAL HEALTH INC | $2,997,491 | – | 31,696 | +100.0% | 2.62% | – |
| QGEN | Sell | QIAGEN NV | $2,823,741 | -65.6% | 62,708 | -64.9% | 2.46% | -41.6% |
| ANTM | Sell | ELEVANCE HEALTH INC | $2,504,018 | -85.4% | 5,636 | -84.9% | 2.19% | -75.2% |
| MDT | New | MEDTRONIC PLC | $2,394,646 | – | 27,181 | +100.0% | 2.09% | – |
| EHC | Buy | ENCOMPASS HEALTH CORP | $2,214,794 | +54.7% | 32,710 | +23.6% | 1.93% | +162.8% |
| VTR | New | VENTAS INC | $1,965,250 | – | 41,575 | +100.0% | 1.72% | – |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $1,901,140 | -29.6% | 368,438 | -28.1% | 1.66% | +19.6% |
| INSM | Sell | INSMED INC | $1,676,838 | -57.2% | 79,471 | -65.4% | 1.46% | -27.3% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $1,317,750 | – | 175,000 | +100.0% | 1.15% | – |
| ZTS | Sell | ZOETIS INCcl a | $1,316,201 | -6.0% | 7,643 | -9.2% | 1.15% | +59.8% |
| BRKR | New | BRUKER CORP | $1,126,984 | – | 15,246 | +100.0% | 0.98% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $999,657 | -56.3% | 2,565 | -58.2% | 0.87% | -25.7% |
| BLUE | Sell | BLUEBIRD BIO INC | $925,941 | -44.5% | 281,441 | -46.4% | 0.81% | -5.8% |
| SELB | Sell | SELECTA BIOSCIENCES INC | $768,480 | -74.5% | 686,143 | -68.3% | 0.67% | -56.6% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $759,460 | -58.0% | 821,038 | -50.6% | 0.66% | -28.7% |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $728,945 | – | 9,153 | +100.0% | 0.64% | – |
| ETNB | Buy | 89BIO INC | $554,894 | +86.0% | 29,282 | +49.5% | 0.48% | +216.3% |
| KIDS | New | ORTHOPEDIATRICS CORP | $470,993 | – | 10,741 | +100.0% | 0.41% | – |
| MASI | New | MASIMO CORP | $468,968 | – | 2,850 | +100.0% | 0.41% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INCcall | $380,286 | – | 57,100 | +100.0% | 0.33% | – |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $362,862 | – | 40,184 | +100.0% | 0.32% | – |
| VKTX | Sell | VIKING THERAPEUTICS INC | $336,422 | -64.6% | 20,754 | -63.6% | 0.29% | -39.8% |
| VKTX | Exit | VIKING THERAPEUTICS INCcall | $0 | – | -442 | -100.0% | -0.00% | – |
| Exit | ATHENEX INC | $0 | – | -42,651 | -100.0% | -0.03% | – | |
| ADXN | Exit | ADDEX THERAPEUTICS LTDsponsored ads | $0 | – | -120,748 | -100.0% | -0.06% | – |
| BDSX | Exit | BIODESIX INC | $0 | – | -113,267 | -100.0% | -0.11% | – |
| BTAI | Exit | BIOXCEL THERAPEUTICS INC | $0 | – | -11,640 | -100.0% | -0.11% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -20,753 | -100.0% | -0.15% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -64,956 | -100.0% | -0.23% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -80,455 | -100.0% | -0.25% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -9,144 | -100.0% | -0.31% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -83,891 | -100.0% | -0.35% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -9,283 | -100.0% | -0.62% | – |
| RMD | Exit | RESMED INC | $0 | – | -6,345 | -100.0% | -0.71% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -34,508 | -100.0% | -0.72% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -71,040 | -100.0% | -0.74% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -9,153 | -100.0% | -0.75% | – |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -540,657 | -100.0% | -0.77% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -64,704 | -100.0% | -0.81% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -29,586 | -100.0% | -0.96% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -3,744 | -100.0% | -1.11% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -55,992 | -100.0% | -1.13% | – |
| PEAK | Exit | HEALTHPEAK PROPERTIES INC | $0 | – | -100,685 | -100.0% | -1.14% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -22,185 | -100.0% | -1.32% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -53,247 | -100.0% | -1.32% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -7,312 | -100.0% | -1.34% | – |
| PFE | Exit | PFIZER INC | $0 | – | -73,265 | -100.0% | -1.54% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -9,185 | -100.0% | -2.26% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -225,615 | -100.0% | -2.45% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -36,130 | -100.0% | -2.85% | – |
| ICLR | Exit | ICON PLC | $0 | – | -26,830 | -100.0% | -2.94% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $0 | – | -762,264 | -100.0% | -3.46% | – |
| SBRA | Exit | SABRA HEALTH CARE REIT INC | $0 | – | -1,165,923 | -100.0% | -6.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.